Skip to main content
NIH funding notice RFA-CA-19-032

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

Closed on August 3, 2020.

Posted
January 24, 2019
Close date
August 3, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,455,269 in first-year total cost, median $577,902.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-1 (J2)]6
  2. Special Emphasis Panel[ZCA1 RPRB-H (J2)]4

Most frequent institutions

  1. WEILL MEDICAL COLL OF CORNELL UNIV2
  2. CASE WESTERN RESERVE UNIVERSITY1
  3. JOHNS HOPKINS UNIVERSITY1
  4. KAISER FOUNDATION RESEARCH INSTITUTE1
  5. OHIO STATE UNIVERSITY1
Competing awards under RFA-CA-19-032 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma1R01CA260691-01CESARMAN, ETHELNIXON, DOUGLAS FWEILL MEDICAL COLL OF CORNELL UNIV, NY$1,200,301ZCA1
2021(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV1R01CA260689-01CHIAO, ELIZABETH Y.SILVERBERG, MICHAEL JKAISER FOUNDATION RESEARCH INSTITUTE, CA$807,377ZCA1
2021(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis1R01CA250072-01A1MESRI, ENRIQUE AROY, SABITAUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$578,253ZCA1
2021(PQ4) Role of HIV-induced PLK1 Activation in Regulation of gamma-Herpesvirus Reservoirs in Lymphocytes1R01CA260690-01SANTOSO, NETTY GOHIO STATE UNIVERSITY, OH$388,148ZCA1
2020Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers1R01CA250069-01AMBINDER, RICHARD FREDERICKXIAN, RENAJOHNS HOPKINS UNIVERSITY, MD$800,059ZCA1
2020(PQ1) HIV-infected T-cell exosomes in lung cancer progression1R01CA250067-01JIN, GEWANG, BINGCHENGCASE WESTERN RESERVE UNIVERSITY, OH$732,429ZCA1
2020(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma1R01CA250065-01HONG, YOUNG-KWONUNIVERSITY OF SOUTHERN CALIFORNIA, CA$577,551ZCA1
2020PQ6: Transgenic Mouse Model for Kaposi Sarcoma1R01CA250080-01DITTMER, DIRK PSIN, SANG-HOONUNIV OF NORTH CAROLINA CHAPEL HILL, NC$529,632ZCA1
2020(PQ#2) Transposable element-mediated gene regulation in KSHV-associated cancer1R01CA250051-01KARIJOLICH, JOHNVANDERBILT UNIVERSITY MEDICAL CENTER, TN$424,580ZCA1
2020(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment1R01CA250074-01CESARMAN, ETHELWEILL MEDICAL COLL OF CORNELL UNIV, NY$416,939ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-19-032: Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) | ScienceDex | ConductScience